Facebook
X
LinkedIn
ForwardMeningococcal Myth Busters: Strategies to Build Vaccine Confidence and Boost Uptake
1.0 NAPNAP Contact Hour. This continuing education activity is offered free to NAPNAP Members and for non- members.
Join us to get up-to-date with the latest data on meningococcal vaccines and recommendations and learn more about risk factors for invasive meningococcal disease. Our expert panelists discuss the importance of evidence-based messaging and effective strategies to counter meningococcal vaccine misinformation.
Educational Partner
Partners for Advancing Clinical Education (Partners) in partnership with Decera Clinical Education
Support Statement
This educational activity is supported by an independent medical education grant from GSK.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the pretest questions, view the content, and complete the CE posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. If a satisfactory score on the posttest is achieved, NAPNAP will issue a NAPNAP CE Contact Hours Certificate.
Copyright Statement
CE Questions?
Contact us at
Contact us at [email protected]
Target Audience
This educational activity is intended for nurse practitioners who provide vaccine services for children and adolescents.
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
1. Counsel patients and families on the risk of invasive meningococcal disease and benefits of vaccination
2. Apply the latest meningococcal vaccine recommendations to clinical practice, including use of pentavalent vaccines when appropriate
3. Develop strategies to overcome barriers to meningococcal vaccination
Faculty:
Mary Koslap-Petraco, DNP, PPCNP, CPNP, FAANP
Clinical Assistant Professor
Stony Brook University School of Nursing
Nurse Consultant
Immunize.org
Owner/NP Pediatric Nurse Practitioner House Calls
Stony Brook, New York
Jana Shaw, MD, MPH, MSc, FPIDS, FAAP
SUNY Upstate Medical University
Professor
Department of Emergency Medicine
SUNY Upstate Medical University
Syracuse NY
Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Partners policies. Others involved in the planning of this activity have no relevant financial relationships.
Primary Author
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP, has no relevant financial relationships to disclose.
Jana Shaw, MD, MPH, MS, FAAP, FPIDS: consultant/advisor/speaker: GSK, Pfizer, Premier, Sanofi.
Support Statement
This educational activity is supported by an independent medical education grant from GSK.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Additional Disclosures
Learners have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Accreditation and Credit Designation
This program is accredited by the National Association of Pediatric Nurse Practitioners (NAPNAP) for 1.0 NAPNAP CE contact hour, of which 1.0 is pharmacology (Rx) content.
This enduring material is approved for 1 year from the date of original release, August 1, 2026 to July 31, 2027.
Available Credit
- 1.00 Contact hours